Phase 1 Growth Hormone Deficiency Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
SafetyTolerabilityAdult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07016802
Completed
Phase 1
A trial comparing ACP-011 administered as a single dose via a syringe and needle versus an auto-injector
Growth failure in children due to Growth Hormone Deficiency
Ascendis Pharma Endocrinology Division A/S26 enrolled1 locationACTRN12617001471370